INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 299 filers reported holding INTELLIA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 1.39 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $452,008 | -80.7% | 14,295 | -78.7% | 0.02% | -86.3% |
| Q4 2022 | $2,344,329 | +402.0% | 67,192 | +704.5% | 0.12% | +588.9% |
| Q3 2022 | $467,000 | -87.5% | 8,352 | -88.5% | 0.02% | -88.9% |
| Q2 2022 | $3,747,000 | +15.7% | 72,400 | +62.5% | 0.16% | +16.5% |
| Q1 2022 | $3,238,000 | +155.4% | 44,554 | +315.5% | 0.14% | +73.8% |
| Q4 2021 | $1,268,000 | -19.9% | 10,723 | -9.1% | 0.08% | -29.8% |
| Q3 2021 | $1,583,000 | +438.4% | 11,800 | +118.5% | 0.11% | +128.0% |
| Q4 2020 | $294,000 | – | 5,400 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 1,216,340 | $62,958,000 | 7.04% |
| Discovery Value Fund | 584,483 | $30,253,000 | 6.33% |
| MPM BioImpact LLC | 299,409 | $15,497,000 | 4.30% |
| ARK Investment Management | 9,514,580 | $439,003,000 | 2.60% |
| Elmwood Wealth Management, Inc. | 67,899 | $3,514,000 | 2.00% |
| Nikko Asset Management Americas, Inc. | 2,781,136 | $141,143,000 | 1.74% |
| Avidity Partners Management LP | 1,125,194 | $58,240,000 | 1.34% |
| Merlin Capital, Inc | 12,174 | $630,000 | 1.26% |
| Atlas Venture Associates IX, LLC | 10,000 | $518,000 | 1.18% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 111,440 | $5,768,000 | 1.16% |